The peptide correction of neurotic disorders among professional truck-drivers
Comparison in people · 2012
- What was studied
- 150 male lorry drivers and 150 male metal craftsmen in the occupational comparison
- Main finding
- The abstract describes occupational psychoemotional differences and reports changes with peptide bioregulators, including combined Pinealon and Vezugen.
Related evidence maps: Military & occupational ↗
Reported findings and study design
150 male lorry drivers (43.3 ± 0.9 years) and 150 male metal craftsmen (42.8 ± 0.9 years); three psychological-adaptation categories.
Population or model 150 male lorry drivers and 150 male metal craftsmen in the occupational comparison
Protocol information
The indexed abstract names Pinealon and Vezugen, including combined use, but gives no dose, route or treatment duration. The separate locomotive-worker capsule regimen is not a verified protocol for these truck drivers.
Protocol source ↗ · Indexed publication abstract; original methods not retrieved
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Sociodemographic associations | Not statistically significant | p>0.1 |
| Peptide-associated psychoemotional/adaptation changes | Statistically significant range reported | p<0.001–0.05 |
| Preferred combination in the authors’ report | Pinealon + Vesugen | Separate treatment-arm sizes and absolute outcome changes not stated |
The 300-person occupational comparison is not a verified randomized-treatment denominator.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- The occupational cohort size is not a verified randomized-treatment sample size.
- Randomization, blinding, and intervention-group sizes are not established from the abstract.
- Combination findings do not identify either peptide’s independent contribution or demonstrate fewer driving accidents.
Source details
PubMed record and English abstract checked; intervention allocation and full methods not reviewed.
Sources checked
Citation
A. S. Bashkireva, V. G. Artamonova. The peptide correction of neurotic disorders among professional truck-drivers Adv Gerontol. 25(4):718–728
Related compounds
Pinealon
A synthetic tripeptide, Glu–Asp–Arg (EDR). Researchers have examined its effects in neuronal aging models and measured functional outcomes in human performance studies.
Vesugen
A synthetic three-amino-acid peptide (Lys–Glu–Asp, or KED) studied in vascular and cell-aging research.